Literature DB >> 23796617

Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia.

Saurabh Kumar1, Tomos E Walters, Karen Halloran, Joseph B Morton, Graham Hepworth, Christopher X Wong, Peter M Kistler, Prashanthan Sanders, Jonathan M Kalman.   

Abstract

AIMS: Percutaneous coronary intervention (PCI) and catheter ablation are well-accepted therapeutic interventions for treatment of coronary artery disease and atrial fibrillation (AF), respectively. We sought to examine temporal trends in the provision of these services over the past decade in Australia. METHODS AND
RESULTS: A retrospective review of the numbers of PCIs and AF ablations from 2000/01 to 2009/10 was performed on data from three sources: the Australian Institute of Health, Welfare and Aging (AIHW), Medicare Australia database (MA), and local records at a high volume tertiary referral centre (RMH) for AF ablation. Linear regression models were fitted comparing trends in population-adjusted procedural numbers over the 10-year period. There was a 5% per year population-adjusted increment in PCIs over 10 years from both the AIHW and MA sources, respectively (P < 0.001). This was similar to the growth rate of all cardiovascular procedures (AIHW: 5.1 vs. 3.8%/year, P = 0.27). Atrial fibrillation ablations showed a 30.9, 23.2, and 39.8% per year population-adjusted increment over 10 years from the AIHW, MA, and RMH sources respectively (P < 0.001 for all). Growth of AF ablations was significantly higher than PCIs (P < 0.001 for AIHW and MA sources) and all cardiovascular procedures (AIHW: 30.9 vs. 3.8%/year, P < 0.001).
CONCLUSION: The provision of catheter-based AF ablation services in Australia has increased exponentially over the past decade. Its annual growth rate exceeded that of PCIs and all cardiovascular procedures. Given the increasing epidemic of AF, these data have critical implications for public health policy assessing the adequacy of infrastructure, training, and funding for AF ablation services.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Coronary artery disease; Ischaemic heart disease; Percutaneous coronary intervention

Mesh:

Year:  2013        PMID: 23796617     DOI: 10.1093/europace/eut162

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

1.  Phased multipolar radiofrequency pulmonary vein isolation is as effective and safe as conventional irrigated point-to-point ablation. A prospective randomised 1-year implantable cardiac monitoring device follow-up trial.

Authors:  S J Podd; A N Sulke; C Sugihara; S S Furniss
Journal:  J Interv Card Electrophysiol       Date:  2015-08-27       Impact factor: 1.900

Review 2.  Current diagnostic and treatment strategies for Lutembacher syndrome: the pivotal role of echocardiography.

Authors:  Leopold Ndemnge Aminde; Anastase Dzudie; Noah Fongwen Takah; Kathleen Blackett Ngu; Karen Sliwa; Andre Pascal Kengne
Journal:  Cardiovasc Diagn Ther       Date:  2015-04

Review 3.  Uninterrupted anticoagulation with non-vitamin K antagonist oral anticoagulants in atrial fibrillation catheter ablation: Lessons learned from randomized trials.

Authors:  Rhanderson Cardoso; Stephan Willems; Edward P Gerstenfeld; Atul Verma; Richard Schilling; Stefan H Hohnloser; Ken Okumura; Matias Nordaby; Marc A Brouwer; Hugh Calkins
Journal:  Clin Cardiol       Date:  2018-12-07       Impact factor: 2.882

Review 4.  Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?

Authors:  Tze-Fan Chao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Fa-Po Chung; Jo-Nan Liao; Shih-Ann Chen
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

5.  Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.

Authors:  Alan Sugrue; Christopher V DeSimone; Charles J Lenz; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2015-12-09       Impact factor: 1.900

6.  Variations in follow-up after atrial fibrillation ablation.

Authors:  Kathryn A Wood; Angel H Barnes
Journal:  J Am Assoc Nurse Pract       Date:  2020-05-06       Impact factor: 1.165

Review 7.  Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.

Authors:  Jonathan Nyong; Guy Amit; Alma J Adler; Onikepe O Owolabi; Pablo Perel; David Prieto-Merino; Pier Lambiase; Juan Pablo Casas; Carlos A Morillo
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

Review 8.  Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians.

Authors:  Nebojša Mujović; Milan Marinković; Radoslaw Lenarczyk; Roland Tilz; Tatjana S Potpara
Journal:  Adv Ther       Date:  2017-07-21       Impact factor: 3.845

Review 9.  Catheter Ablation of Atrial Fibrillation: A Review of the Current Status and Future Directions.

Authors:  Daniel P Melby
Journal:  J Innov Card Rhythm Manag       Date:  2017-11-15

10.  Utility of High-frequency Jet Ventilation in Atrial Fibrillation Ablation.

Authors:  Savalan Babapoor-Farrokhran; Jafar Alzubi; Zachary Port; Ola Khraisha; Sumeet K Mainigi
Journal:  J Innov Card Rhythm Manag       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.